1. Home
  2. ANIP vs STC Comparison

ANIP vs STC Comparison

Compare ANIP & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • STC
  • Stock Information
  • Founded
  • ANIP 2001
  • STC 1893
  • Country
  • ANIP United States
  • STC United States
  • Employees
  • ANIP N/A
  • STC N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • STC Specialty Insurers
  • Sector
  • ANIP Health Care
  • STC Finance
  • Exchange
  • ANIP Nasdaq
  • STC Nasdaq
  • Market Cap
  • ANIP 2.0B
  • STC 2.0B
  • IPO Year
  • ANIP N/A
  • STC N/A
  • Fundamental
  • Price
  • ANIP $90.08
  • STC $70.95
  • Analyst Decision
  • ANIP Strong Buy
  • STC Buy
  • Analyst Count
  • ANIP 9
  • STC 2
  • Target Price
  • ANIP $82.89
  • STC $77.50
  • AVG Volume (30 Days)
  • ANIP 696.2K
  • STC 189.8K
  • Earning Date
  • ANIP 08-08-2025
  • STC 07-23-2025
  • Dividend Yield
  • ANIP N/A
  • STC 2.83%
  • EPS Growth
  • ANIP N/A
  • STC 99.80
  • EPS
  • ANIP N/A
  • STC 3.11
  • Revenue
  • ANIP $747,399,000.00
  • STC $2,668,739,000.00
  • Revenue This Year
  • ANIP $31.40
  • STC $13.62
  • Revenue Next Year
  • ANIP $7.38
  • STC $12.41
  • P/E Ratio
  • ANIP N/A
  • STC $22.71
  • Revenue Growth
  • ANIP 38.68
  • STC 13.92
  • 52 Week Low
  • ANIP $52.50
  • STC $56.39
  • 52 Week High
  • ANIP $91.01
  • STC $78.44
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 80.26
  • STC 66.03
  • Support Level
  • ANIP $85.44
  • STC $69.72
  • Resistance Level
  • ANIP $68.18
  • STC $72.80
  • Average True Range (ATR)
  • ANIP 3.40
  • STC 1.39
  • MACD
  • ANIP 1.96
  • STC 0.34
  • Stochastic Oscillator
  • ANIP 96.69
  • STC 78.03

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

Share on Social Networks: